Elicio Therapeutics Inc
NASDAQ:ELTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Elicio Therapeutics Inc
NASDAQ:ELTX
|
US |
|
Burford Capital Ltd
F:9BFA
|
GG |
|
Kinarus Therapeutics Holding AG
SIX:CURN
|
CH |
|
Cross Country Healthcare Inc
NASDAQ:CCRN
|
US |
|
S
|
Scientex Bhd
KLSE:SCIENTX
|
MY |
|
Corning Inc
SIX:GLW
|
US |
|
Assicurazioni Generali SpA
MIL:G
|
IT |
|
C
|
Canadian Pacific Kansas City Ltd
F:X88
|
CA |
|
Grail Inc
F:NL0
|
US |
|
P
|
PostNL NV
LSE:0P47
|
NL |
|
C
|
Caixabank SA
XMUN:48CA
|
ES |
|
P
|
Pensionbee Group PLC
LSE:PBEE
|
UK |
|
P
|
Palatin Technologies Inc
LSE:0KF3
|
US |
|
Petroleo Brasileiro SA Petrobras
F:PJXB
|
BR |
|
L
|
Longino & Cardenal SpA
MIL:LON
|
IT |
Wall St Price Targets
ELTX Price Targets Summary
Elicio Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
ELTX is 21.08 USD with a low forecast of 12.12 USD and a high forecast of 28.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ELTX's stock price target?
Price Target
21.08
USD
According to Wall Street analysts, the average 1-year price target for
ELTX is 21.08 USD with a low forecast of 12.12 USD and a high forecast of 28.35 USD.